Last updated on: 8/24/2007 | Author: ProCon.org

Multidisciplinary Association for Psychedelic Studies (MAPS) Biography

Position:
Pro to the question "Should Marijuana Be a Medical Option?"
Reasoning:

“MAPS, in association with Prof. Lyle Craker, UMass Amherst Dept. of Plant and Soil Sciences, is in the midst of the process of seeking DEA permission to establish a medical marijuana production facility to grow high-potency marijuana for FDA-approved research.”

Jan. 2002

Theoretical Expertise Ranking:
  Organizations/VIPs/Others
Individuals and organizations that do not fit into the other star categories.
Description:

“The Multidisciplinary Association for Psychedelic Studies (MAPS) is a membership-based, IRS-approved 501(c)(3) non-profit research and educational organization. We assist scientists to design, fund, obtain approval for and report on studies into the risks and benefits of MDMA, psychedelic drugs and marijuana.”

“MAPS Homepage,” MAPS website (accessed Aug. 21, 2007)

Mission:

“MAPS’ mission is to sponsor scientific research designed to develop psychedelics and marijuana into FDA-approved prescription medicines, and to educate the public honestly about the risks and benefits of these drugs.”

“MAPS Homepage,” MAPS website (accessed Aug. 21, 2007)

Other:
Nonprofit 501(c)(3)
Quoted in:
  1. Is the US Food and Drug Administration (FDA) Approval Process Subverted by Passing Bills and State Initiatives That Legalize Medical Marijuana?